Schonfeld Strategic Advisors LLC Agios Pharmaceuticals, Inc. Transaction History
Schonfeld Strategic Advisors LLC
- $14.6 Billion
- Q2 2024
A detailed history of Schonfeld Strategic Advisors LLC transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 464,121 shares of AGIO stock, worth $21.1 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
464,121Holding current value
$21.1 Million% of portfolio
0.14%Shares
12 transactions
Others Institutions Holding AGIO
# of Institutions
228Shares Held
56.3MCall Options Held
275KPut Options Held
251K-
Farallon Capital Management LLC San Francisco, CA5.65MShares$257 Million1.18% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.5MShares$249 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$221 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.88MShares$176 Million2.8% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.78MShares$126 Million0.01% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $2.49B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...